Yufan Xiang

514 total citations
16 papers, 379 citations indexed

About

Yufan Xiang is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Yufan Xiang has authored 16 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Yufan Xiang's work include Glioma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Yufan Xiang is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Yufan Xiang collaborates with scholars based in China, United States and Portugal. Yufan Xiang's co-authors include Zhongwei Gu, Kui Luo, Qiyong Gong, Junhong Li, Yujun Zeng, Hu Zhang, Yan‐Hui Liu, Yanhui Liu, Helena Tomás and Song Chen and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Yufan Xiang

15 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufan Xiang China 9 129 115 95 59 59 16 379
Pallavi R. Gangalum United States 11 207 1.6× 169 1.5× 153 1.6× 80 1.4× 77 1.3× 17 540
Josep Balart Spain 8 97 0.8× 93 0.8× 92 1.0× 31 0.5× 47 0.8× 9 297
Duaa Abuarqoub Jordan 14 163 1.3× 90 0.8× 104 1.1× 79 1.3× 56 0.9× 47 463
Thibaut Fourniols Belgium 5 110 0.9× 148 1.3× 139 1.5× 49 0.8× 22 0.4× 7 314
Hongzhi Xu China 13 118 0.9× 70 0.6× 112 1.2× 37 0.6× 40 0.7× 28 374
Tessa M. Simone United States 12 305 2.4× 79 0.7× 100 1.1× 27 0.5× 86 1.5× 20 608
Ayşe Gülten Kantarcı Türkiye 9 256 2.0× 141 1.2× 145 1.5× 23 0.4× 63 1.1× 15 440
Tiep Tien Nguyen South Korea 13 159 1.2× 107 0.9× 75 0.8× 68 1.2× 34 0.6× 29 483
Mengting Zhu China 12 187 1.4× 137 1.2× 50 0.5× 55 0.9× 44 0.7× 34 517

Countries citing papers authored by Yufan Xiang

Since Specialization
Citations

This map shows the geographic impact of Yufan Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufan Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufan Xiang more than expected).

Fields of papers citing papers by Yufan Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufan Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufan Xiang. The network helps show where Yufan Xiang may publish in the future.

Co-authorship network of co-authors of Yufan Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufan Xiang. A scholar is included among the top collaborators of Yufan Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufan Xiang. Yufan Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Siliang, Junhong Li, Yufan Xiang, et al.. (2025). Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1/2 signaling. Oncogene. 44(47). 4657–4670.
2.
Li, Wenhao, et al.. (2024). Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection. Frontiers in Oncology. 14. 1462424–1462424. 1 indexed citations
3.
Li, Tengfei, et al.. (2024). Research progress on platelets in glioma. Chinese Medical Journal. 138(1). 28–37. 1 indexed citations
4.
Xiang, Yufan, Bing Wang, Wanchun Yang, et al.. (2024). Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy. Advanced Materials. 36(18). e2311500–e2311500. 15 indexed citations
5.
Wang, Zhihao, Yi Liu, Shuxin Zhang, et al.. (2023). Effects of iron homeostasis on epigenetic age acceleration: a two-sample Mendelian randomization study. Clinical Epigenetics. 15(1). 159–159. 10 indexed citations
6.
Fan, Huanhuan, Shuxin Zhang, Siliang Chen, et al.. (2023). Glutamine metabolism-related genes predict prognosis and reshape tumor microenvironment immune characteristics in diffuse gliomas. Frontiers in Neurology. 14. 1104738–1104738. 2 indexed citations
7.
Xiang, Yufan, Zhiqian Li, Dayi Pan, et al.. (2023). Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis. SHILAP Revista de lepidopterología. 5(2). 4 indexed citations
8.
Li, Junhong, Huanhuan Fan, Xingwang Zhou, Yufan Xiang, & Yanhui Liu. (2022). Prognostic Significance and Gene Co-Expression Network of PLAU and PLAUR in Gliomas. Frontiers in Oncology. 11. 602321–602321. 16 indexed citations
9.
Xiang, Yufan, Chen Huang, Yan He, & Qin Zhang. (2021). Cancer or Tuberculosis: A Comprehensive Review of the Clinical and Imaging Features in Diagnosis of the Confusing Mass. Frontiers in Oncology. 11. 644150–644150. 19 indexed citations
10.
Zeng, Yujun, Yufan Xiang, Ruilong Sheng, et al.. (2021). Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioactive Materials. 6(10). 3358–3382. 113 indexed citations
11.
Li, Junhong, Xingwang Zhou, Yufan Xiang, et al.. (2021). Clinical Significance of Preoperative Fibrinogen to Albumin Ratio in Patients with Glioblastoma: A Singe Center Experience. Cancer Management and Research. Volume 13. 3259–3269. 7 indexed citations
12.
Li, Junhong, et al.. (2021). Prognostic Significance of Preoperative Albumin to Alkaline Phosphatase Ratio in Patients with Glioblastoma. Journal of Cancer. 12(19). 5950–5959. 6 indexed citations
13.
Cai, Hao, Yufan Xiang, Yujun Zeng, et al.. (2020). Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment. Acta Pharmaceutica Sinica B. 11(2). 544–559. 91 indexed citations
14.
Li, Junhong, Ruofei Liang, Song Chen, Yufan Xiang, & Yan‐Hui Liu. (2019). Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis. Critical Reviews in Eukaryotic Gene Expression. 29(2). 141–150. 11 indexed citations
15.
Li, Junhong, et al.. (2018). Prognostic and clinicopathological significance of long non-coding RNA in glioma. Neurosurgical Review. 43(1). 1–8. 17 indexed citations
16.
Li, Junhong, et al.. (2018). Prognostic significance of epidermal growth factor receptor expression in glioma patients. OncoTargets and Therapy. Volume 11. 731–742. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026